Necrotizing fasciitis with slow progression in a patient with rheumatoid arthritis receiving tocilizumab

被引：1
作者：
Goto, Kazuya [1 ]
Kogame, Toshiaki [1 ]
Kusuba, Nobuhiro [1 ]
Endo, Yuichiro [1 ]
Dainichi, Teruki [1 ,2 ]
Kabashima, Kenji [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan
[2] Kagawa Univ, Fac Med, Dept Dermatol, Takamatsu, Kagawa, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2022年 / 32卷 / 02期
关键词：
D O I：
10.1684/ejd.2022.4249
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：279 / 280
页数：2
相关论文
共 11 条
  • [1] Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective
    De Keyser, Filip
    [J]. CURRENT RHEUMATOLOGY REVIEWS, 2011, 7 (01) : 77 - 87
  • [2] Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
    Gupta, Shruti
    Wang, Wei
    Hayek, Salim S.
    Chan, Lili
    Mathews, Kusum S.
    Melamed, Michal L.
    Brenner, Samantha K.
    Leonberg-Yoo, Amanda
    Schenck, Edward J.
    Radbel, Jared
    Reiser, Jochen
    Bansal, Anip
    Srivastava, Anand
    Zhou, Yan
    Finkel, Diana
    Green, Adam
    Mallappallil, Mary
    Faugno, Anthony J.
    Zhang, Jingjing
    Velez, Juan Carlos Q.
    Shaefi, Shahzad
    Parikh, Chirag R.
    Charytan, David M.
    Athavale, Ambarish M.
    Friedman, Allon N.
    Redfern, Roberta E.
    Short, Samuel A. P.
    Correa, Simon
    Pokharel, Kapil K.
    Admon, Andrew J.
    Donnelly, John P.
    Gershengorn, Hayley B.
    Douin, David J.
    Semler, Matthew W.
    Hernan, Miguel A.
    Leaf, David E.
    [J]. JAMA INTERNAL MEDICINE, 2021, 181 (01) : 41 - 51
  • [3] Manabe Saki, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-222826
  • [4] Matsuo Hiroo, 2015, Kansenshogaku Zasshi, V89, P53
  • [5] Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles
    Miller, LG
    Perdreau-Remington, F
    Rieg, G
    Mehdi, S
    Perlroth, J
    Bayer, AS
    Tang, AW
    Phung, TO
    Spellberg, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (14) : 1445 - 1453
  • [6] Norrby-Teglund A, 2000, EUR J IMMUNOL, V30, P3247, DOI 10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO
  • [7] 2-D
  • [8] Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study
    Pawar, Ajinkya
    Desai, Rishi J.
    Solomon, Daniel H.
    Ortiz, Adrian J. Santiago
    Gale, Sara
    Bao, Min
    Sarsour, Khaled
    Schneeweiss, Sebastian
    Kim, Seoyoung C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (04) : 456 - 464
  • [9] Necrotizing fasciitis in a patient receiving tocilizumab for rheumatoid arthritis - Case report
    Rosa-Goncalves, Diana
    Bernardes, Miguel
    Costa, Lucia
    [J]. REUMATOLOGIA CLINICA, 2018, 14 (03): : 168 - 170
  • [10] Necrotizing Fasciitis
    Shimizu, Taro
    Tokuda, Yasuharu
    [J]. INTERNAL MEDICINE, 2010, 49 (12) : 1051 - 1057
12